ArticleBritish journal of cancer2022

A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinoma.

Yuma Wada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.